Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201611177013N15Phase 3Completed
Phase 3 trial of remifentanil in None, sponsored by Tabriz University of Medical Sciences. Started Dec 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201611177013N15.